Ivana Purnama Dewi, - and Louisa Fadjri Kusuma Wardhani, - and Kristin Purnama Dewi, - and Iswanto, - and Andrianto, - (2021) The role of vitamin D and cardiovascular risk in COVID-19 patients. Cardiovascular and Metabolic Science, 32 (3). pp. 149-156. ISSN 2383-2828
Text (Similarity)
C6-Similarity.pdf Download (2MB) |
|
Text (Peer Review)
C6-Peer Review.pdf Download (1MB) |
|
Text (Artikel)
C6-Artikel_compressed.pdf Download (2MB) |
Abstract
Vitamin D deficiency has long been associated with the incidence of cardiovascular disease. It also thought to play a role in the severity of COVID-19 patients. A serum concentration of 25(OH) D < 50 nmol/L (vitamin D deficiency) is found in patient with severe COVID-19 manifestation requiring intensive care. These patients are thought to stem from an uncontrolled complex immune response. The role of vitamin D in the COVID-19 infection reaction is by supporting antimicrobial peptides response in the respiratory epithelium and reducing inflammatory reactions to SARS-CoV-2 infection. Therefore, it can reduce the severity of COVID-19 infection. Vitamin D has also involved in several cardiovascular diseases that could increase the severity of COVID-19 infection; i.e., hypertension, lipid metabolism, atherosclerosis, and heart failure. Vitamin D affects endothelial cell function, thus regulating vasodilatation of dependent endothelial cells. It can prevent atherosclerosis and vascular calcification, which COVID-19 patients are at an increased risk. It also reduces pro-inflammatory cytokines, which has an anti-remodelling effect to reducing the fatality risk of obesity and heart failure among COVID-19 patients. Understanding the importance of avoiding vitamin D deficiency, the fulfilment of daily intake should be taken into account. The recommended daily dose of vitamin D is 200 IU per day for those aged < 50 years, 400 IU per day for those aged 50-70 years and 600 IU for individuals aged > 70 years. It is estimated that for every 100 IU of vitamin D, the 25(OH)D level increases by 2.5 nmol/L.
Item Type: | Article | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uncontrolled Keywords: | Vitamin D deficiency, vitamin D and COVID-19, cardiovascular disease | ||||||||||||
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC666-701 Diseases of the circulatory (Cardiovascular) system |
||||||||||||
Divisions: | 01. Fakultas Kedokteran > Ilmu Penyakit Jantung | ||||||||||||
Creators: |
|
||||||||||||
Depositing User: | arys fk | ||||||||||||
Date Deposited: | 29 Mar 2022 04:44 | ||||||||||||
Last Modified: | 29 Mar 2022 04:44 | ||||||||||||
URI: | http://repository.unair.ac.id/id/eprint/114407 | ||||||||||||
Sosial Share: | |||||||||||||
Actions (login required)
View Item |